Implemented a third-party allocation of new shares.


Tokyo, November 20, 2018  

 

 

Noile-immune Biotech announces Implementing financing on October 31, 2018 by a third-party allocation of new shares to Yamaguchi Technology Licensing Organization, Ltd. With this funding Noile-immune will not only strengthen the relationship with this company and Yamaguchi University, but also accelerate R&D.